APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neuroleptics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Neuroleptics Market Analysis and Forecast 2026-2032

21 December 2025194 pages

Choose your research edition.

Industry ResearchNeuroleptics Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuroleptics Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Neuroleptics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuroleptics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuroleptics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Neuroleptics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Neuroleptics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Neuroleptics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Neuroleptics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Neuroleptics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Neuroleptics include Johnson & Johnson, Eli Lilly, Pfizer, GSK, Bristol-Myers Squibb, AstraZeneca and Allergan, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Neuroleptics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neuroleptics, also provides the sales of main regions and countries. Of the upcoming market potential for Neuroleptics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neuroleptics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neuroleptics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Neuroleptics sales, projected growth trends, production technology, application and end-user industry.

Neuroleptics Segment by Company

Johnson & Johnson

Eli Lilly

Pfizer

GSK

Bristol-Myers Squibb

AstraZeneca

Allergan

Neuroleptics Segment by Type

First Generation

Second Generation

Third Generation

Neuroleptics Segment by Application

Bipolar Disorder

Schizophrenia

Unipolar Depression

Dementia

Others

Neuroleptics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuroleptics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuroleptics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuroleptics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Neuroleptics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Neuroleptics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neuroleptics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neuroleptics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. First Generation Major Manufacturers Table 3. Second Generation Major Manufacturers Table 4. Third Generation Major Manufacturers Table 5. Global Neuroleptics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Bipolar Disorder Major Manufacturers Table 7. Schizophrenia Major Manufacturers Table 8. Unipolar Depression Major Manufacturers Table 9. Dementia Major Manufacturers Table 10. Others Major Manufacturers Table 11. Neuroleptics Industry Trends Table 12. Neuroleptics Industry Drivers Table 13. Neuroleptics Industry Opportunities and Challenges Table 14. Neuroleptics Industry Restraints Table 15. Global Neuroleptics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Neuroleptics Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Neuroleptics Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Neuroleptics Revenue Market Share by Region (2021-2026) Table 19. Global Neuroleptics Revenue Market Share by Region (2027-2032) Table 20. Global Neuroleptics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 21. Global Neuroleptics Sales by Region (2021-2026) & (k tons) Table 22. Global Neuroleptics Sales by Region (2027-2032) & (k tons) Table 23. Global Neuroleptics Sales Market Share by Region (2021-2026) Table 24. Global Neuroleptics Sales Market Share by Region (2027-2032) Table 25. Global Neuroleptics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Neuroleptics Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Neuroleptics Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Neuroleptics Sales Market Share by Manufacturers (2021-2026) Table 29. Global Neuroleptics Sales Price (US$/ton) of Manufacturers (2021-2026) Table 30. Global Neuroleptics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Neuroleptics Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Neuroleptics Manufacturers, Product Type & Application Table 33. Global Neuroleptics Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Neuroleptics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Neuroleptics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Neuroleptics Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Neuroleptics Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Neuroleptics Revenue Market Share by Type (2021-2026) Table 40. Global Neuroleptics Revenue Market Share by Type (2027-2032) Table 41. Global Neuroleptics Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 42. Global Neuroleptics Sales by Type (2021-2026) & (k tons) Table 43. Global Neuroleptics Sales by Type (2027-2032) & (k tons) Table 44. Global Neuroleptics Sales Market Share by Type (2021-2026) Table 45. Global Neuroleptics Sales Market Share by Type (2027-2032) Table 46. Global Neuroleptics Price by Type (2021-2026) & (US$/ton) Table 47. Global Neuroleptics Price by Type (2027-2032) & (US$/ton) Table 48. Global Neuroleptics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Neuroleptics Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Neuroleptics Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Neuroleptics Revenue Market Share by Application (2021-2026) Table 52. Global Neuroleptics Revenue Market Share by Application (2027-2032) Table 53. Global Neuroleptics Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 54. Global Neuroleptics Sales by Application (2021-2026) & (k tons) Table 55. Global Neuroleptics Sales by Application (2027-2032) & (k tons) Table 56. Global Neuroleptics Sales Market Share by Application (2021-2026) Table 57. Global Neuroleptics Sales Market Share by Application (2027-2032) Table 58. Global Neuroleptics Price by Application (2021-2026) & (US$/ton) Table 59. Global Neuroleptics Price by Application (2027-2032) & (US$/ton) Table 60. Johnson & Johnson Company Information Table 61. Johnson & Johnson Business Overview Table 62. Johnson & Johnson Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 63. Johnson & Johnson Neuroleptics Product Portfolio Table 64. Johnson & Johnson Recent Development Table 65. Eli Lilly Company Information Table 66. Eli Lilly Business Overview Table 67. Eli Lilly Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 68. Eli Lilly Neuroleptics Product Portfolio Table 69. Eli Lilly Recent Development Table 70. Pfizer Company Information Table 71. Pfizer Business Overview Table 72. Pfizer Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 73. Pfizer Neuroleptics Product Portfolio Table 74. Pfizer Recent Development Table 75. GSK Company Information Table 76. GSK Business Overview Table 77. GSK Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 78. GSK Neuroleptics Product Portfolio Table 79. GSK Recent Development Table 80. Bristol-Myers Squibb Company Information Table 81. Bristol-Myers Squibb Business Overview Table 82. Bristol-Myers Squibb Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 83. Bristol-Myers Squibb Neuroleptics Product Portfolio Table 84. Bristol-Myers Squibb Recent Development Table 85. AstraZeneca Company Information Table 86. AstraZeneca Business Overview Table 87. AstraZeneca Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 88. AstraZeneca Neuroleptics Product Portfolio Table 89. AstraZeneca Recent Development Table 90. Allergan Company Information Table 91. Allergan Business Overview Table 92. Allergan Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 93. Allergan Neuroleptics Product Portfolio Table 94. Allergan Recent Development Table 95. North America Neuroleptics Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Neuroleptics Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Neuroleptics Sales by Type (2021-2026) & (k tons) Table 98. North America Neuroleptics Sales by Type (2027-2032) & (k tons) Table 99. North America Neuroleptics Sales Price by Type (2021-2026) & (US$/ton) Table 100. North America Neuroleptics Sales Price by Type (2027-2032) & (US$/ton) Table 101. North America Neuroleptics Revenue by Application (2021-2026) & (US$ Million) Table 102. North America Neuroleptics Revenue by Application (2027-2032) & (US$ Million) Table 103. North America Neuroleptics Sales by Application (2021-2026) & (k tons) Table 104. North America Neuroleptics Sales by Application (2027-2032) & (k tons) Table 105. North America Neuroleptics Sales Price by Application (2021-2026) & (US$/ton) Table 106. North America Neuroleptics Sales Price by Application (2027-2032) & (US$/ton) Table 107. North America Neuroleptics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. North America Neuroleptics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. North America Neuroleptics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. North America Neuroleptics Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 111. North America Neuroleptics Sales by Country (2021-2026) & (k tons) Table 112. North America Neuroleptics Sales by Country (2027-2032) & (k tons) Table 113. North America Neuroleptics Sales Price by Country (2021-2026) & (US$/ton) Table 114. North America Neuroleptics Sales Price by Country (2027-2032) & (US$/ton) Table 115. United States Neuroleptics Revenue (2021-2032) & (US$ Million) Table 116. Canada Neuroleptics Revenue (2021-2032) & (US$ Million) Table 117. Mexico Neuroleptics Revenue (2021-2032) & (US$ Million) Table 118. Europe Neuroleptics Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Neuroleptics Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Neuroleptics Sales by Type (2021-2026) & (k tons) Table 121. Europe Neuroleptics Sales by Type (2027-2032) & (k tons) Table 122. Europe Neuroleptics Sales Price by Type (2021-2026) & (US$/ton) Table 123. Europe Neuroleptics Sales Price by Type (2027-2032) & (US$/ton) Table 124. Europe Neuroleptics Revenue by Application (2021-2026) & (US$ Million) Table 125. Europe Neuroleptics Revenue by Application (2027-2032) & (US$ Million) Table 126. Europe Neuroleptics Sales by Application (2021-2026) & (k tons) Table 127. Europe Neuroleptics Sales by Application (2027-2032) & (k tons) Table 128. Europe Neuroleptics Sales Price by Application (2021-2026) & (US$/ton) Table 129. Europe Neuroleptics Sales Price by Application (2027-2032) & (US$/ton) Table 130. Europe Neuroleptics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe Neuroleptics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. Europe Neuroleptics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. Europe Neuroleptics Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 134. Europe Neuroleptics Sales by Country (2021-2026) & (k tons) Table 135. Europe Neuroleptics Sales by Country (2027-2032) & (k tons) Table 136. Europe Neuroleptics Sales Price by Country (2021-2026) & (US$/ton) Table 137. Europe Neuroleptics Sales Price by Country (2027-2032) & (US$/ton) Table 138. Germany Neuroleptics Revenue (2021-2032) & (US$ Million) Table 139. France Neuroleptics Revenue (2021-2032) & (US$ Million) Table 140. U.K. Neuroleptics Revenue (2021-2032) & (US$ Million) Table 141. Italy Neuroleptics Revenue (2021-2032) & (US$ Million) Table 142. Russia Neuroleptics Revenue (2021-2032) & (US$ Million) Table 143. Spain Neuroleptics Revenue (2021-2032) & (US$ Million) Table 144. Netherlands Neuroleptics Revenue (2021-2032) & (US$ Million) Table 145. Switzerland Neuroleptics Revenue (2021-2032) & (US$ Million) Table 146. Sweden Neuroleptics Revenue (2021-2032) & (US$ Million) Table 147. Poland Neuroleptics Revenue (2021-2032) & (US$ Million) Table 148. China Neuroleptics Revenue by Type (2021-2026) & (US$ Million) Table 149. China Neuroleptics Revenue by Type (2027-2032) & (US$ Million) Table 150. China Neuroleptics Sales by Type (2021-2026) & (k tons) Table 151. China Neuroleptics Sales by Type (2027-2032) & (k tons) Table 152. China Neuroleptics Sales Price by Type (2021-2026) & (US$/ton) Table 153. China Neuroleptics Sales Price by Type (2027-2032) & (US$/ton) Table 154. China Neuroleptics Revenue by Application (2021-2026) & (US$ Million) Table 155. China Neuroleptics Revenue by Application (2027-2032) & (US$ Million) Table 156. China Neuroleptics Sales by Application (2021-2026) & (k tons) Table 157. China Neuroleptics Sales by Application (2027-2032) & (k tons) Table 158. China Neuroleptics Sales Price by Application (2021-2026) & (US$/ton) Table 159. China Neuroleptics Sales Price by Application (2027-2032) & (US$/ton) Table 160. Asia Neuroleptics Revenue by Type (2021-2026) & (US$ Million) Table 161. Asia Neuroleptics Revenue by Type (2027-2032) & (US$ Million) Table 162. Asia Neuroleptics Sales by Type (2021-2026) & (k tons) Table 163. Asia Neuroleptics Sales by Type (2027-2032) & (k tons) Table 164. Asia Neuroleptics Sales Price by Type (2021-2026) & (US$/ton) Table 165. Asia Neuroleptics Sales Price by Type (2027-2032) & (US$/ton) Table 166. Asia Neuroleptics Revenue by Application (2021-2026) & (US$ Million) Table 167. Asia Neuroleptics Revenue by Application (2027-2032) & (US$ Million) Table 168. Asia Neuroleptics Sales by Application (2021-2026) & (k tons) Table 169. Asia Neuroleptics Sales by Application (2027-2032) & (k tons) Table 170. Asia Neuroleptics Sales Price by Application (2021-2026) & (US$/ton) Table 171. Asia Neuroleptics Sales Price by Application (2027-2032) & (US$/ton) Table 172. Asia Neuroleptics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Asia Neuroleptics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. Asia Neuroleptics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. Asia Neuroleptics Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 176. Asia Neuroleptics Sales by Country (2021-2026) & (k tons) Table 177. Asia Neuroleptics Sales by Country (2027-2032) & (k tons) Table 178. Asia Neuroleptics Sales Price by Country (2021-2026) & (US$/ton) Table 179. Asia Neuroleptics Sales Price by Country (2027-2032) & (US$/ton) Table 180. Japan Neuroleptics Revenue (2021-2032) & (US$ Million) Table 181. South Korea Neuroleptics Revenue (2021-2032) & (US$ Million) Table 182. India Neuroleptics Revenue (2021-2032) & (US$ Million) Table 183. Australia Neuroleptics Revenue (2021-2032) & (US$ Million) Table 184. Taiwan Neuroleptics Revenue (2021-2032) & (US$ Million) Table 185. Southeast Asia Neuroleptics Revenue (2021-2032) & (US$ Million) Table 186. SAMEA Neuroleptics Revenue by Type (2021-2026) & (US$ Million) Table 187. SAMEA Neuroleptics Revenue by Type (2027-2032) & (US$ Million) Table 188. SAMEA Neuroleptics Sales by Type (2021-2026) & (k tons) Table 189. SAMEA Neuroleptics Sales by Type (2027-2032) & (k tons) Table 190. SAMEA Neuroleptics Sales Price by Type (2021-2026) & (US$/ton) Table 191. SAMEA Neuroleptics Sales Price by Type (2027-2032) & (US$/ton) Table 192. SAMEA Neuroleptics Revenue by Application (2021-2026) & (US$ Million) Table 193. SAMEA Neuroleptics Revenue by Application (2027-2032) & (US$ Million) Table 194. SAMEA Neuroleptics Sales by Application (2021-2026) & (k tons) Table 195. SAMEA Neuroleptics Sales by Application (2027-2032) & (k tons) Table 196. SAMEA Neuroleptics Sales Price by Application (2021-2026) & (US$/ton) Table 197. SAMEA Neuroleptics Sales Price by Application (2027-2032) & (US$/ton) Table 198. SAMEA Neuroleptics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. SAMEA Neuroleptics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 200. SAMEA Neuroleptics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 201. SAMEA Neuroleptics Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 202. SAMEA Neuroleptics Sales by Country (2021-2026) & (k tons) Table 203. SAMEA Neuroleptics Sales by Country (2027-2032) & (k tons) Table 204. SAMEA Neuroleptics Sales Price by Country (2021-2026) & (US$/ton) Table 205. SAMEA Neuroleptics Sales Price by Country (2027-2032) & (US$/ton) Table 206. Brazil Neuroleptics Revenue (2021-2032) & (US$ Million) Table 207. Argentina Neuroleptics Revenue (2021-2032) & (US$ Million) Table 208. Chile Neuroleptics Revenue (2021-2032) & (US$ Million) Table 209. Colombia Neuroleptics Revenue (2021-2032) & (US$ Million) Table 210. Peru Neuroleptics Revenue (2021-2032) & (US$ Million) Table 211. Saudi Arabia Neuroleptics Revenue (2021-2032) & (US$ Million) Table 212. Israel Neuroleptics Revenue (2021-2032) & (US$ Million) Table 213. UAE Neuroleptics Revenue (2021-2032) & (US$ Million) Table 214. Turkey Neuroleptics Revenue (2021-2032) & (US$ Million) Table 215. Iran Neuroleptics Revenue (2021-2032) & (US$ Million) Table 216. Egypt Neuroleptics Revenue (2021-2032) & (US$ Million) Table 217. Key Raw Materials Table 218. Raw Materials Key Suppliers Table 219. Neuroleptics Distributors List Table 220. Neuroleptics Customers List Table 221. Research Programs/Design for This Report Table 222. Authors List of This Report Table 223. Secondary Sources Table 224. Primary Sources List of Figures Figure 1. Neuroleptics Image Figure 2. Global Neuroleptics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuroleptics Market Size Share 2021 VS 2025 VS 2032 Figure 4. First Generation Image Figure 5. Second Generation Image Figure 6. Third Generation Image Figure 7. Global Neuroleptics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Neuroleptics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Bipolar Disorder Image Figure 10. Schizophrenia Image Figure 11. Unipolar Depression Image Figure 12. Dementia Image Figure 13. Others Image Figure 14. Global Neuroleptics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Neuroleptics Revenue (2021-2032) & (US$ Million) Figure 16. Global Neuroleptics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Neuroleptics Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Neuroleptics Revenue Market Share by Region (2021-2032) Figure 19. Global Neuroleptics Sales (2021-2032) & (k tons) Figure 20. Global Neuroleptics Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 21. Global Neuroleptics Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Neuroleptics Sales YoY (2021-2032) & (k tons) Figure 23. Europe Neuroleptics Sales YoY (2021-2032) & (k tons) Figure 24. China Neuroleptics Sales YoY (2021-2032) & (k tons) Figure 25. Asia (Excluding China) Neuroleptics Sales YoY (2021-2032) & (k tons) Figure 26. South America, Middle East and Africa Neuroleptics Sales YoY (2021-2032) & (k tons) Figure 27. Global Neuroleptics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Neuroleptics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Neuroleptics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Neuroleptics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Neuroleptics Revenue Market Share by Type (2021-2032) Figure 33. Global Neuroleptics Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 34. Global Neuroleptics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Neuroleptics Sales Market Share by Type (2021-2032) Figure 36. Global Neuroleptics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Neuroleptics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Neuroleptics Revenue Market Share by Application (2021-2032) Figure 39. Global Neuroleptics Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 40. Global Neuroleptics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Neuroleptics Sales Market Share by Application (2021-2032) Figure 42. North America Neuroleptics Revenue Share by Type (2021-2032) Figure 43. North America Neuroleptics Sales Share by Type (2021-2032) Figure 44. North America Neuroleptics Revenue Share by Application (2021-2032) Figure 45. North America Neuroleptics Sales Share by Application (2021-2032) Figure 46. North America Neuroleptics Revenue Share by Country (2021-2032) Figure 47. North America Neuroleptics Sales Share by Country (2021-2032) Figure 48. Europe Neuroleptics Revenue Share by Type (2021-2032) Figure 49. Europe Neuroleptics Sales Share by Type (2021-2032) Figure 50. Europe Neuroleptics Revenue Share by Application (2021-2032) Figure 51. Europe Neuroleptics Sales Share by Application (2021-2032) Figure 52. Europe Neuroleptics Revenue Share by Country (2021-2032) Figure 53. Europe Neuroleptics Sales Share by Country (2021-2032) Figure 54. China Neuroleptics Revenue Share by Type (2021-2032) Figure 55. China Neuroleptics Sales Share by Type (2021-2032) Figure 56. China Neuroleptics Revenue Share by Application (2021-2032) Figure 57. China Neuroleptics Sales Share by Application (2021-2032) Figure 58. Asia Neuroleptics Revenue Share by Type (2021-2032) Figure 59. Asia Neuroleptics Sales Share by Type (2021-2032) Figure 60. Asia Neuroleptics Revenue Share by Application (2021-2032) Figure 61. Asia Neuroleptics Sales Share by Application (2021-2032) Figure 62. Asia Neuroleptics Revenue Share by Country (2021-2032) Figure 63. Asia Neuroleptics Sales Share by Country (2021-2032) Figure 64. SAMEA Neuroleptics Revenue Share by Type (2021-2032) Figure 65. SAMEA Neuroleptics Sales Share by Type (2021-2032) Figure 66. SAMEA Neuroleptics Revenue Share by Application (2021-2032) Figure 67. SAMEA Neuroleptics Sales Share by Application (2021-2032) Figure 68. SAMEA Neuroleptics Revenue Share by Country (2021-2032) Figure 69. SAMEA Neuroleptics Sales Share by Country (2021-2032) Figure 70. Neuroleptics Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Neuroleptics Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • First Generation
  • Second Generation
  • Third Generation
Applications
  • Bipolar Disorder
  • Schizophrenia
  • Unipolar Depression
  • Dementia
  • Others
Companies covered
  • Johnson & Johnson
  • Eli Lilly
  • Pfizer
  • GSK
  • Bristol-Myers Squibb
  • AstraZeneca
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neuroleptics Market by Type
  3. 1.2.1 Global Neuroleptics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 First Generation
  5. 1.2.3 Second Generation
  6. 1.2.4 Third Generation
  7. 1.3 Neuroleptics Market by Application
  8. 1.3.1 Global Neuroleptics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Bipolar Disorder
  10. 1.3.3 Schizophrenia
  11. 1.3.4 Unipolar Depression
  12. 1.3.5 Dementia
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Neuroleptics Market Dynamics
  1. 2.1 Neuroleptics Industry Trends
  2. 2.2 Neuroleptics Industry Drivers
  3. 2.3 Neuroleptics Industry Opportunities and Challenges
  4. 2.4 Neuroleptics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Neuroleptics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Neuroleptics Revenue by Region
  3. 3.2.1 Global Neuroleptics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neuroleptics Revenue by Region (2021-2026)
  5. 3.2.3 Global Neuroleptics Revenue by Region (2027-2032)
  6. 3.2.4 Global Neuroleptics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Neuroleptics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Neuroleptics Sales by Region
  9. 3.4.1 Global Neuroleptics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Neuroleptics Sales by Region (2021-2026)
  11. 3.4.3 Global Neuroleptics Sales by Region (2027-2032)
  12. 3.4.4 Global Neuroleptics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Neuroleptics Revenue by Manufacturers
  2. 4.1.1 Global Neuroleptics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Neuroleptics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Neuroleptics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neuroleptics Sales by Manufacturers
  6. 4.2.1 Global Neuroleptics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Neuroleptics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Neuroleptics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Neuroleptics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Neuroleptics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Neuroleptics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Neuroleptics Manufacturers, Product Type & Application
  13. 4.7 Global Neuroleptics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Neuroleptics Market CR5 and HHI
  16. 4.8.2 2025 Neuroleptics Tier 1, Tier 2, and Tier 3
5 Neuroleptics Market by Type
  1. 5.1 Global Neuroleptics Revenue by Type
  2. 5.1.1 Global Neuroleptics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Neuroleptics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Neuroleptics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Neuroleptics Sales by Type
  6. 5.2.1 Global Neuroleptics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neuroleptics Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global Neuroleptics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Neuroleptics Price by Type
6 Neuroleptics Market by Application
  1. 6.1 Global Neuroleptics Revenue by Application
  2. 6.1.1 Global Neuroleptics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Neuroleptics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Neuroleptics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Neuroleptics Sales by Application
  6. 6.2.1 Global Neuroleptics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Neuroleptics Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global Neuroleptics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Neuroleptics Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Neuroleptics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Neuroleptics Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Eli Lilly
  8. 7.2.1 Eli Lilly Company Information
  9. 7.2.2 Eli Lilly Business Overview
  10. 7.2.3 Eli Lilly Neuroleptics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly Neuroleptics Product Portfolio
  12. 7.2.5 Eli Lilly Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Neuroleptics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Neuroleptics Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 GSK
  20. 7.4.1 GSK Company Information
  21. 7.4.2 GSK Business Overview
  22. 7.4.3 GSK Neuroleptics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GSK Neuroleptics Product Portfolio
  24. 7.4.5 GSK Recent Developments
  25. 7.5 Bristol-Myers Squibb
  26. 7.5.1 Bristol-Myers Squibb Company Information
  27. 7.5.2 Bristol-Myers Squibb Business Overview
  28. 7.5.3 Bristol-Myers Squibb Neuroleptics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bristol-Myers Squibb Neuroleptics Product Portfolio
  30. 7.5.5 Bristol-Myers Squibb Recent Developments
  31. 7.6 AstraZeneca
  32. 7.6.1 AstraZeneca Company Information
  33. 7.6.2 AstraZeneca Business Overview
  34. 7.6.3 AstraZeneca Neuroleptics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Neuroleptics Product Portfolio
  36. 7.6.5 AstraZeneca Recent Developments
  37. 7.7 Allergan
  38. 7.7.1 Allergan Company Information
  39. 7.7.2 Allergan Business Overview
  40. 7.7.3 Allergan Neuroleptics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Allergan Neuroleptics Product Portfolio
  42. 7.7.5 Allergan Recent Developments
8 North America
  1. 8.1 North America Neuroleptics Market Size by Type
  2. 8.1.1 North America Neuroleptics Revenue by Type (2021-2032)
  3. 8.1.2 North America Neuroleptics Sales by Type (2021-2032)
  4. 8.1.3 North America Neuroleptics Price by Type (2021-2032)
  5. 8.2 North America Neuroleptics Market Size by Application
  6. 8.2.1 North America Neuroleptics Revenue by Application (2021-2032)
  7. 8.2.2 North America Neuroleptics Sales by Application (2021-2032)
  8. 8.2.3 North America Neuroleptics Price by Application (2021-2032)
  9. 8.3 North America Neuroleptics Market Size by Country
  10. 8.3.1 North America Neuroleptics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Neuroleptics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Neuroleptics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Neuroleptics Market Size by Type
  2. 9.1.1 Europe Neuroleptics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Neuroleptics Sales by Type (2021-2032)
  4. 9.1.3 Europe Neuroleptics Price by Type (2021-2032)
  5. 9.2 Europe Neuroleptics Market Size by Application
  6. 9.2.1 Europe Neuroleptics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Neuroleptics Sales by Application (2021-2032)
  8. 9.2.3 Europe Neuroleptics Price by Application (2021-2032)
  9. 9.3 Europe Neuroleptics Market Size by Country
  10. 9.3.1 Europe Neuroleptics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Neuroleptics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Neuroleptics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Neuroleptics Market Size by Type
  2. 10.1.1 China Neuroleptics Revenue by Type (2021-2032)
  3. 10.1.2 China Neuroleptics Sales by Type (2021-2032)
  4. 10.1.3 China Neuroleptics Price by Type (2021-2032)
  5. 10.2 China Neuroleptics Market Size by Application
  6. 10.2.1 China Neuroleptics Revenue by Application (2021-2032)
  7. 10.2.2 China Neuroleptics Sales by Application (2021-2032)
  8. 10.2.3 China Neuroleptics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neuroleptics Market Size by Type
  2. 11.1.1 Asia Neuroleptics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Neuroleptics Sales by Type (2021-2032)
  4. 11.1.3 Asia Neuroleptics Price by Type (2021-2032)
  5. 11.2 Asia Neuroleptics Market Size by Application
  6. 11.2.1 Asia Neuroleptics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Neuroleptics Sales by Application (2021-2032)
  8. 11.2.3 Asia Neuroleptics Price by Application (2021-2032)
  9. 11.3 Asia Neuroleptics Market Size by Country
  10. 11.3.1 Asia Neuroleptics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Neuroleptics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Neuroleptics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neuroleptics Market Size by Type
  2. 12.1.1 SAMEA Neuroleptics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Neuroleptics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Neuroleptics Price by Type (2021-2032)
  5. 12.2 SAMEA Neuroleptics Market Size by Application
  6. 12.2.1 SAMEA Neuroleptics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Neuroleptics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Neuroleptics Price by Application (2021-2032)
  9. 12.3 SAMEA Neuroleptics Market Size by Country
  10. 12.3.1 SAMEA Neuroleptics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Neuroleptics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Neuroleptics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Neuroleptics Value Chain Analysis
  2. 13.1.1 Neuroleptics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Neuroleptics Production Mode & Process
  6. 13.2 Neuroleptics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Neuroleptics Distributors
  9. 13.2.3 Neuroleptics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst